跳至主要内容
临床试验/NCT02881203
NCT02881203已完成不适用

BRAVEHeart - Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart

University of Sydney2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2018年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
2
主要终点
Accuracy of Breathe Well

研究概览

简要总结

This study investigates the Breathe Well device to test whether it is superior to the existing treatment standard of the Varian Realtime Position Management (RPM) system in assisting patients with deep inspiration breath hold.

详细描述

Recent studies have demonstrated an increased risks of cardiac disease in breast cancer radiotherapy patients. For patients diagnosed <50 years old, the risks for cardiovascular diseases/events were increased by 24-82% comparing left and right breast radiotherapy. The deep inspiration breath hold (DIBH) technique addresses this problem by reducing the heart dose by up to half, thus potentially reducing the increased rate of major coronary events by 20%. Providing patients with visual feedback in addition to audio guidance has been demonstrated to improve the reproducibility of the DIBH technique by 95% and stability by 80%.

Breathe Well is a new audiovisual feedback device that may increase the accuracy and workflow of implementing DIBH for breast cancer patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Left-sided breast cancer patients (invasive and in situ)
  • Supine positioning of the patients.
  • Ability to perform a ≥20s breath hold
  • >18 years old
  • An ECOG score in the range of 0 to 2
  • Able to give written informed consent and willingness to participate and comply with the study
  • Patients must be able to read and complete questionnaires in English

排除标准

  • Involvement or at risk regional lymph nodes
  • Pregnant / lactating women

结局指标

主要结局

Accuracy of Breathe Well

时间窗: 2 years

The accuracy will be measured by comparing 'Breathe Well' and RPM measurements with images acquired of the breast during the radiation treatment using an electronic portal imaging device (EPID).

次要结局

  • Patient comfort(2 years)
  • To develop the use of EPID for real time MLC tracking during breast radiotherapy(2 years)
  • To compare actual and planned doses(2 years)
  • Difference in set up times for Breathe Well vs RPM(2 years)
  • Staff perception of Breathe Well(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验